Relumina (relugolix) is an orally active, GnRH receptor antagonist that is used to treat endometriosis and heavy menstrual bleeding associated with uterine fibroids. It works by blocking the release of gonadotropin-releasing hormone (GnRH), which reduces the production of estrogen and testosterone.